CHROMATOGRAPHIC IMMUNOASSAY FOR THE DIRECT AND QUALITATIVE DETECTION OF SARS-CoV-2 ANTIGENS IN NASAL SWABS FROM PATIENTS WITH SIGNS AND SYMPTOMS WHO ARE SUSPECTED OF COVID-19.
IN-VITRO IMMUNOASSEY FOR THE DIRECT AND QUALITATIVE DETECTION OF SARS-CoV-2 VIRAL NUCLEOPROTEIN ANTIGENS FROM NASOPHARYHGEAL SECREATIONS AND OROPHARYNGEAL SECREATIONS.
CAN DEFECT MINIMAL AMOUNTS OF VIRAL GENTEIC MATERIAL IN A SAMPLE BY DUPLICATING IT MANY TIMES OVER THROUGH COMPLEX LABORATORY PROCESS CALLED AMPLIFICATION.
